Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alyssa Swearingen

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Journal of the American Academy of Dermatology|December 26, 2024
Response to Fleshner et al, "Bridging the gap in acne vulgaris research for skin of color patients: Response to: "Assessing the inclusion of post-inflammatory hyperpigmentation outcomes in acne vulgaris clinical trials"Alyssa Swearingen, Christine Olagun-Samuel, Prince Adotama
Dermatology and Therapy|February 8, 2025
CDKN2A Mutation: A Patient's and Physician's ExperienceYaelle Shaked, Alyssa Swearingen, Tracey N Liebman
Arthroplasty Today|December 6, 2017
Comparison of adverse events rates and hospital cost between customized individually made implants and standard off-the-shelf implants for total knee arthroplastySteven D Culler, Greg M Martin, Alyssa Swearingen
Journal of Cosmetic Dermatology|September 24, 2021
Subject satisfaction following treatment with nanofractional radiofrequency for the treatment and reduction of acne scarring and rhytids: A prospective studySuleima Arruda, Alyssa Swearingen, Kathleen Medrano, et al.
Journal of Drugs in Dermatology : JDD|November 4, 2024
A Single-Center, Open-Label, Prospective Study of a 589/1319 nm Dual Wavelength Laser for the Treatment of Facial HyperpigmentationSuleima Arruda, Alyssa Swearingen, Zahyaa Elmadany, et al.
JAMA Dermatology|October 8, 2025
Navigating Melanoma In Situ in the Age of OverdiagnosisYaelle Shaked, Alyssa Swearingen, Jennifer A Stein, et al.
Journal of the American Academy of Dermatology|October 11, 2024
Assessing the inclusion of postinflammatory hyperpigmentation outcomes in acne vulgaris clinical trialsAlyssa Swearingen, Christine Olagun-Samuel, Arielle R Nagler, et al.
Journal of Drugs in Dermatology : JDD|November 7, 2022
Evaluating the Efficacy of Platelet Rich Plasma and 1550 nm Fractional Laser in Combination and Alone for the Management of Androgenetic AlopeciaNatalie Haddad, Suleima Arruda, Alyssa Swearingen, et al.
Journal of Drugs in Dermatology : JDD|May 3, 2021
Randomized, Double-Blind, Placebo-Controlled Study of Poly-L-Lactic acid for Treatment of Cellulite in the Lower ExtremitiesAlyssa Swearingen, Kathleen Medrano, Georgina Ferzli, et al.
Journal of the American Academy of Dermatology|February 19, 2025
The ethics of financial incentives to improve clinical trial diversityAlyssa Swearingen, Albert E Zhou, Jun Lu, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal of the American Academy of Dermatology|December 26, 2024
Response to Fleshner et al, "Bridging the gap in acne vulgaris research for skin of color patients: Response to: "Assessing the inclusion of post-inflammatory hyperpigmentation outcomes in acne vulgaris clinical trials"Alyssa Swearingen, Christine Olagun-Samuel, Prince Adotama
Dermatology and Therapy|February 8, 2025
CDKN2A Mutation: A Patient's and Physician's ExperienceYaelle Shaked, Alyssa Swearingen, Tracey N Liebman
Arthroplasty Today|December 6, 2017
Comparison of adverse events rates and hospital cost between customized individually made implants and standard off-the-shelf implants for total knee arthroplastySteven D Culler, Greg M Martin, Alyssa Swearingen
Journal of Cosmetic Dermatology|September 24, 2021
Subject satisfaction following treatment with nanofractional radiofrequency for the treatment and reduction of acne scarring and rhytids: A prospective studySuleima Arruda, Alyssa Swearingen, Kathleen Medrano, et al.
Journal of Drugs in Dermatology : JDD|November 4, 2024
A Single-Center, Open-Label, Prospective Study of a 589/1319 nm Dual Wavelength Laser for the Treatment of Facial HyperpigmentationSuleima Arruda, Alyssa Swearingen, Zahyaa Elmadany, et al.
JAMA Dermatology|October 8, 2025
Navigating Melanoma In Situ in the Age of OverdiagnosisYaelle Shaked, Alyssa Swearingen, Jennifer A Stein, et al.
Journal of the American Academy of Dermatology|October 11, 2024
Assessing the inclusion of postinflammatory hyperpigmentation outcomes in acne vulgaris clinical trialsAlyssa Swearingen, Christine Olagun-Samuel, Arielle R Nagler, et al.
Journal of Drugs in Dermatology : JDD|November 7, 2022
Evaluating the Efficacy of Platelet Rich Plasma and 1550 nm Fractional Laser in Combination and Alone for the Management of Androgenetic AlopeciaNatalie Haddad, Suleima Arruda, Alyssa Swearingen, et al.
Journal of Drugs in Dermatology : JDD|May 3, 2021
Randomized, Double-Blind, Placebo-Controlled Study of Poly-L-Lactic acid for Treatment of Cellulite in the Lower ExtremitiesAlyssa Swearingen, Kathleen Medrano, Georgina Ferzli, et al.
Journal of the American Academy of Dermatology|February 19, 2025
The ethics of financial incentives to improve clinical trial diversityAlyssa Swearingen, Albert E Zhou, Jun Lu, et al.
Pageof 3